N/A N=62 Ultrasound Based Acoustic Radiation Force Impulse Imaging
Liver Fibrosis · Liver Inflammation
Primary: ARFI/VTQ and ARFI/VTIQ Liver Shear Wave Speed vs. Liver Histologic Fibrosis Score — 1.69; 2.01 m/s — p=<0.0001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=1,346 A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)
Psoriasis
Primary: Number of Participants Achieving a Static Physician Global Assessment (sPGA) of (0, 1) (Efficacy of Ixekizumab in Participants With Moderate to Severe Chronic Plaque…
Phase 3 N=335 Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection
Hepatitis C Virus · HIV
Primary: Percentage of Participants With Sustained Virologic Response (SVR) 12 Weeks After Discontinuation of Therapy (SVR12) — 96.1 percentage of participants
Phase 1 N=46 Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment
Solid Tumors · Hematologic Malignancies · Hepatic Impairment
Primary: Area Under the Concentration Time Curve From Time Zero to Last Concentration Measured (AUC0-last) of Carfilzomib 27 mg/m² — 378; 546; 477 ng*hr/mL — p=0.02232
Phase 2 N=13 Stroke Feasibility Study
Atrial Fibrillation · AFib
Primary: Number of Serious Adverse Events Within 30 Days Post-Index Procedure — 0 participants
N/A N=505 Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Primary Open Angle Glaucoma (POAG) · Cataract
Primary: Proportion of Eyes With ≥ 20% Decrease in Intraocular Pressure (IOP) From Baseline to the Hypotensive Medication-free 24-month Postoperative Examination Using…
Phase 2 N=34 Effect of CD07805/47 Gel in Rosacea Flushing
Rosacea
Primary: Total Number of Flushes for Each 2-week Period — 15.3; 16.3 Flushes count — p=0.7420
N/A N=30 CO-OPerative Training for Stroke Rehabilitation
CO-OP · Attention Control
Primary: Difference in Independence With Activities of Daily Living (Functional Independence Measure) Between Groups Over Time — 65.27; 62.60; 86.80; 80.53 units on a scale…
Phase 4 N=14 DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)
Hepatitis C, Chronic
Primary: SVR12 (Sustain Virological Response, HCV RNA Undetectable 12 Weeks Post-treatment) — 71; 100; 100 percentage of participants
N/A N=80 Use of Ibuprofen and Acetaminophen for Treatment of Acute Headache Post Concussion in Children
Concussion · Headache
Primary: Number of Headache Days — 4; 3; 3; 4 number of headache days
N/A N=43 Examining Rehabilitation Training Methods
Guided Training · Directed Training
Primary: Differences in Independence With Activities of Daily Living (Functional Independence Measure) Between Groups Over Time — 67.33; 67.32; 86.86; 89.05 units on a scale…
N/A N=48 Shoulder Eccentric External Rotator Training for Subacromial Pain Syndrome
Subacromial Impingement Syndrome
Primary: Change in Western Ontario Rotator Cuff Index — 92.72; 77.15 units on a scale derived from 100cm vas
Phase 3 N=1,224 A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)
Psoriasis
Primary: Percentage of Participants With a Static Physician Global Assessment (sPGA) of (0,1) (Efficacy of Ixekizumab in Participants With Moderate to Severe Chronic Plaque…
N/A N=55 Exercise Therapy Program in Ankylosing Spondylitis Patients
Ankylosing Spondylitis
Primary: FUNCTIONAL INDEX — 3.4; 4.3; 3.2; 4.5 units on a scale — p=0.13
N/A N=104 Multidisciplinary Evaluation of Patients With Hemophilia
Haemophilia
Primary: Assess the Joint Damage — 0.36; 0 points